Diseases & Disorders
(G96)
IRS Verified
DX Registered
990 on File
ALEX MANFULL FUND
Financial strength (30%)
93/100
Reliability (20%)
40/100
Effectiveness (25%)
90/100
Impact (25%)
85/100
CharityAI™ Score
Not yet evaluated
Mission Statement
The Alex Manfull Fund is dedicated to advancing research, education, and awareness on infection-associated neuroimmune psychiatric disorders—commonly known as PANDAS and PANS—with a particular focus on their impact in adolescents and young adults. Our vision is to ensure that no life is ever again lost or derailed by a neuroimmune disorder. By addressing critical gaps in care and driving systemic change, we strive toward a future where comprehensive, patient-centered, and equitable treatment is the universal standard.
Financial Overview — FY 2024
$245K
Total Revenue
$247K
Total Expenses
N/A
Net Assets
1
Employees
Program Expense Ratio
N/A
Fundraising Efficiency
0.0%
Operating Reserve
N/A
Liability-to-Asset
0.0%
Revenue Diversification
N/A
Executive Compensation
$0
Compared with Peers
FY 2023
Compared with 2,093 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.9% | 83.4% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
13.1% | 11.3% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.1% |
P10P90
|
Top quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
0.0% | 18.4% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
17.4 mo | 12.3 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.9% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
72.7% | 95.3% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
94.1% | 9.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
57.0% | 14.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
50.9% | 0.9% |
P10P90
|
Impact
3 programs| Outcome / Program | People Served | Cost / Service | # Completed | Duration |
|---|---|---|---|---|
| Increase awareness on PANS/PANDAS | 800 | $1.00 | — | Per Day |
| Increase awareness on PANS/PANDAS | 7,000 | $2.00 | — | Per Day |
| Increase clinician education on PANS/PANDAS | 320 | $1.00 | — | Per Day |
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $245K | $247K | N/A | — | 1 |
| 2023 | $230K | $113K | $164K | 86.9% | 0 |
| 2022 | $119K | $72K | $47K | 58.4% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.